Sex and gender issues and venous thromboembolism
- 30 June 2004
- journal article
- review article
- Published by Elsevier BV in Clinics in Chest Medicine
- Vol. 25 (2), 281-297
- https://doi.org/10.1016/j.ccm.2004.01.013
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisThe New England Journal of Medicine, 2000
- Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over studyThe Lancet, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Tamoxifen and risk of idiopathic venous thromboembolismBritish Journal of Clinical Pharmacology, 1998
- Increased fetal loss in women with heritable thrombophiliaThe Lancet, 1996
- A new noninvasive management strategy for patients with suspected pulmonary embolismArchives of Internal Medicine, 1989
- Epidemiological observations of thrombo-embolic disease during pregnancy and in the puerperium, in 56,022 womenInternational Journal of Gynecology & Obstetrics, 1983